Trial Profile
Phase I Study of Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children With Relapsed and Refractory Solid Tumors and Leukemias
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jan 2024
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary) ; Cyclophosphamide (Primary) ; Etoposide (Primary)
- Indications Leukaemia; Solid tumours
- Focus Adverse reactions
- 10 Jan 2024 Status changed from active, no longer recruiting to completed.
- 12 Sep 2023 Status changed from recruiting to active, no longer recruiting.
- 06 Jul 2021 Planned End Date changed from 1 Dec 2020 to 1 Jun 2024.